Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Loretta Nastoupil, MD, University of Texas MD Anderson Center, Houston, TX, discusses the research gaps and unmet needs in oral therapies for lymphoid cancers, and how these can be addressed in order to maximize their effectiveness. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.